Nasobronchial relationship after cold air provocation  by JOHANSSON, Å. et al.
Nasobronchial relationship after cold air provocation
A˚. JOHANSSON*, M. BENDE{, E. MILLQVIST{ AND B. BAKE{
*Department of Lung Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg and {Department
of Otorhinolaryngology, Central Hospital, Sko¨vde, Sweden
Provocation with cold air in the nose causes broncho-obstruction while warm air causes bronchodilation in patients
with asthma, but not in healthy subjects. These findings have suggested the existence of a nasobronchial reflex. The
present study aimed to block this effect and evaluate the mechanisms underlying the effect on lung function after
cold stimulation of the nose. Lung function, as measured with specific conductance and forced expiratory flow, was
reduced after cold stimulation of the nose, but this effect could not be blocked by anesthetizing the nose or by
inhaling an anti-cholinergic drug before the provocation. These results confirm the presence of a nasobronchial
relationship, but not of a nasobronchial reflex.
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Inhalation of cold air is known to induce airway obstruc-
tion in sensitive asthmatic patients. This has been attributed
to heat and water losses from the airway mucosa causing
bronchoconstriction (1–6). Patients often report that the
obstruction begins rapidly after exposure to cold air and
that damp, cold weather near freezing point causes more
breathing problems than colder, dry air. These circum-
stances appear inconsistent with the heat- and water-loss
theory, so this may not be the only mechanism involved in
the effects of cold on the airways of patients with asthma.
In an uncontrolled study of 27 patients it was found that
a single cold stimulation in the nose of asthmatic patients,
but not in healthy controls, induces bronchoconstriction
(7). This effect could be blocked by inhaling an anti-
cholinergic drug before the cold provocation (7). In another
study, nasal inhalation of cold dry air or of dry air alone
reduced lung function. These effects were inhibited by
anaesthizing the nose or inhaling an anticholinergic drug
(8). A reflex from the upper airways, hastening the onset of
obstruction, was suggested, but the studies were not
controlled and cold air administered via the nose would
probably reach the intra-pulmonary airways. Therefore, in
a previous study, we evaluated how changes in nasal air
temperature affected lung function, when care was taken to
avoid the temperature changes in the nose from reaching
the lower airways (9). In patients with asthma, but not in
healthy ones, cold air administered in and around the noseReceived 3 April 2000 and accepted in revised form 29 June 2000.
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bronchodilation, while ambient air had no effect. These
results are consistent with, but do not establish, the
existence of a nasobronchial reflex.
The aim of the present investigation was to evaluate the
mechanisms underlying the effect on lung function after
cold stimulation of the nose. We studied whether the effect
on the lower airways could be blocked by anaesthizing the
nose and by inhaling an anti-cholinergic drug before the
cold provocation.
Material and methods
Ten patients (six women, four men, 22–44 years, mean
32 years) took part in this study. They all have a history of
cold-sensitive asthma, objectively shown in a standardized
cold challenge test. All patients had a history of atopy and
had earlier shown an increase of at least 20% in FEV1 after
inhaling a b2-agonist. They were adequately treated
(various corticosteroids for inhalation, short- and long-
acting b2-agonists) and had a predicted value of more than
90% FEV1. On most days, they had no symptoms of
asthma and none of them smoked. No medication was
taken for a minimum of 12 h before any test. Long-acting
bronchodilators were withheld for at least 24 h.
Each patient was provoked with cold air in the nose on
two occasions, either after local anaesthesia of the nose
combined with inhalation of an anti-cholinergic drug, or
after placebo. The order was randomized and the interval
was 1–2 weeks. The drugs were given during a rest period of
1 h prior to the provocation. The nasal mucosa was sprayed
intermittently with lidocaine (40mgml71), total 5ml and
5 g EMLA1 cream (containing lidocaine and prilocaine;# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Lung function tests were carried out when the
patients arrived at the laboratory and after 1 h rest. During
this period, local anaesthetic or placebo was applied to the
nose and an anti-cholinergic drug or placebo was inhaled.
Initial After 1 h rest
SGAW Active substance 3?5+0?5 8?7+3?0
(lkPa716sec) Placebo 3?4+0?8 5?2+0?7
FEV1 Active substance 3?2+0?3 3?5+0?3
(1) Placebo 3?3+0?4 3?5+0?4
FIG. 1. Changes in SGAW after nasal provocations with
cold air. The results are shown as mean values and SE
expressed in percentage of the preprovocation values.
Active treatment (*), placebo (&).
FIG. 2. Changes in FEV1 after nasal provocations with
cold air. The results are shown as mean values expressed
in percentage of the preprovocation values. Active
treatment (*), placebo (&).
1120 A˚. JOHANSSON ET. AL.Astra, Sweden) was applied to the tip of the nose and in
both vestibulum nasi. In addition, the patient inhaled
0?6mg ipratropium bromide dry powder (Atrovent1;
Boeringer, Ingelheim, Germany) by the mouth. Placebos
were applied in the same way. The drugs were given in a
randomized order by one investigator, while the lung
function tests were performed by another, unaware of
which drug was used.
The provocations with cold air (about 7158C) were
performed on separate days, at approximately the same
time each day, in a similar way, as reported elsewhere (9).
With each nasal provocation, an airstream (about
0?8 l sec71) was blown into one nostril via a nose halter.
One provocation consisted of 10 puffs of air of 15 sec
duration, each at intervals of 1min between the puffs.
Shortly before each puff of air, the patients took a deep
breath and blew into a mouthpiece with a small hole
connected to a pressure-meter. Positive intra-thoracic and
intra-oral pressures were thereby maintained during the
provocation and for a few seconds thereafter. A constant
positive mouth pressure excluded any leakage of air from
the nose to the lower airways during nasal provocations.
The airflow entering one nostril came out through the
other, passing the nasopharynx. In the halter, just at the
edge of the nose, thermistors recorded the temperature of
the inflow and outflow air. The temperatures and the mouth
pressure were recorded on a direct writer. The patients kept
notes as to whether they had had any diculty in breathing
by using a four-grade symptom-score, where 0 was no
symptoms and 3, severe symptoms.
Specific airway conductance (SGAW; 1 kPa716sec) and
1 sec of forced expiratory volumes (FEV1; l) were deter-
mined at the first time when the patients arrived at the
laboratory, after resting for 1 h, i.e. just before, and
immediately (0min) and 5, 10 and 15min after the
provocations. SGAW was determined in a body plethysmo-
graph (Transmural body box 2800, Sensormedics Co, Iorba
LINDA, CA, U.S.A.) and FEV1 with a spirometer
(Vitalograph, Buckingham, U.K.). Recordings of SGAW
always preceded those of FEV1 and the recordings were
evaluated blindly.
The effects of these provocations were analysed by
calculating ‘the area under the curve’—i.e. an expression
of the overall difference from baseline, by using ANOVA
and the Wilcoxon sign rank test. P-values less than 0?05
were considered significant. Results are presented as
mean+SE. The study was approved by the local ethics
committee.
Results
Both SGAW and FEV1 increased significantly (P50?01)
during the rest period of 1 h after the patients entered the
laboratory. Among patients given active treatment, SGAW
and FEV1 increased more, compared to when placebos
were given, but the differences were not statistically
significant (Table 1).
Stimulation with cold air in the nose induced bronch-
oobstruction, as measured with SGAW and FEV1 (Figs 1and 2). The decrease in lung function was statistically
significant (P50?05), measured with both techniques.
However, there was no significant difference between the
effect of active treatment, compared to that of placebo.
The symptom scores showed that the asthmatic
patients were essentially asymptomatic before the provoca-
tions. After provocation with cold air, two patients
reported minor breathing problems, while four noted
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from 0?7 to 0?5 (NS).
Discussion
An interaction between the nose and the lower airways is
confirmed by the present results and by those of the
previous study (9). In animal experiments, mechanical
stimulation of the nasal mucosa or insuation of chemical
irritating agents into the nose has induced a reduction in
airway resistance (10), in others, induced a reduction in
minute volume (11) or had no effects on the airways at all
(12). In healthy humans, chemical stimuli in the nose and
nasopharyngeal area cause an increase in airway resistance
(13). Atropine given intravenously prevents this effect, thus
indicating a reflex mechanism involving the trigeminal and
vagal nerves. Although the existence of a nasobronchial
reflex seems likely, it has not been convincingly demon-
strated in man. Cooling of the skin of the face or total body
seems to trigger bronchoconstriction, both in patients with
asthma and healthy subjects (14,15)
As in our previous paper, greater reductions in lung
function were measured with body plethysmography than
with spirometry (9). The percentage decrease in SGAW after
cold provocation was about 25% 10–15min after the
provocation, which accorded with earlier findings. The
corresponding figures for FEV1 were only a few percent.
The effect of blocking the sensory system of the nose and
pretreatment with an anticholinergic drug did not inhibit
the relationship between the nose and the lungs in this
study. As anaesthesia was excessive, our findings do not
favour a nasobronchial reflex from the sensory nerve
system of the nose. Furthermore, we were not able to
repeat previous findings that inhalation of an anti-
cholinergic drug or nasal treatment with an anaesthetic
before cold stimulation in the nose could block an increase
of the resistance in the lower airways of asthmatic patients
(7,8). In an additional experiment on a single subject, we
infiltrated the area around the nose with an anaesthetic and
gave ordinary anaesthesia. However, we found no tendency
to inhibition of the effect of cold provocation on the lower
airways.
Explanations of our results, other than a nasobronchial
reflex, must therefore be considered. Inflammatory media-
tors released after cold provocation of the nose or a cooling
effect of the body might be involved (16). However, cold air
had an immediate effect on lung function and it seem
unlikely that mediators released in the circulation could act
so quickly. In recent years, the effect of nitric oxide (NO) on
lung function has been evaluated (17,18). NO is continously
produced in human nasal airways, mainly by the paranasal
sinuses, which are ventilated by the respiratory cycle (19).
Immediately after the provocation, part of the air inspired
into the sinuses reaches the lungs via the nasal–sinus
ostium. The factors that regulate NO synthesis in the upper
airways are still not known, but the ostium might be less
open when exposed to cold than when exposed to warm air,
resulting in less NO admixture to the inhaled air, due to
changes in mucosal congestion (20). Thus, the temperatureof the nasal air is presumably important for the amount of
NO reaching the lower airways. NO from the sinuses may
cause a weak bronchodilation after provocation with warm
air and a weak bronchobstruction after cold air in the nose.
Support for this theory is that NO can exert a broncho-
dilatory effect in patients with asthma but not in healthy
ones (21).
In our previous study, we found that baseline values of
SGAW and FEV1 varied in patients with asthma, indicating
labile lung function even when the patients were asympto-
matic (9). However, in healthy normal subjects, the baseline
varied less. In the present study, to stabilize the baseline
values, the patients rested 1 h before the provocation.
During this period, lung function improved considerably
and those who were given active treatment improved more,
probably an effect of ipratropium bromide. Therefore, they
started at a higher level and the percentage reduction in
lung function after cold provocation was more pronounced.
In conclusion, as in our previous study, provocation with
cold air in the nose caused airflow limitation confirming the
existence of an interaction between the nose and the lower
airways. This effect could not be blocked by pretreatment
with local anaesthesia of the nose in combination with
inhalation of impratropium bromide, which provides
evidence against a nasobronchial neurogenic reflex. We
speculate that the mechanism may be related to reduced
ventilation with nitric oxide from the paranasal sinuses.
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